Sweeney; Zachary Kevin
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sweeney; Zachary Kevin.The latest application filed is for "isoxazole hydroxamic acid compounds as lpxc inhibitors".
Company Profile
0.45.47
- Sweeney; Zachary Kevin - Redwood City CA
- SWEENEY; Zachary Kevin - US
Patent Activity
| Patent | Date |
|---|---|
| Hepatitis C virus inhibitors Grant 10,407,445 - Qiu , et al. Sept | 2019-09-10 |
| Crystalline isoxazole hydroxamic acid compounds Grant 10,071,973 - Fu , et al. September 11, 2 | 2018-09-11 |
| Isoxazole hydroxamic acid compounds as LpxC inhibitors Grant 10,029,994 - Fu , et al. July 24, 2 | 2018-07-24 |
| ISOXAZOLE HYDROXAMIC ACID COMPOUNDS AS LpxC INHIBITORS App 20180030004 - FU; Jiping ; et al. | 2018-02-01 |
| Crystalline Isoxazole Hydroxamic Acid Compounds App 20170355684 - FU; Jiping ; et al. | 2017-12-14 |
| Isoxazole hydroxamic acid compounds as LpxC inhibitors Grant 9,815,804 - Fu , et al. November 14, 2 | 2017-11-14 |
| 2'-ethynyl nucleoside derivatives for treatment of viral infections Grant 9,814,739 - Anandan , et al. November 14, 2 | 2017-11-14 |
| Isoxazoline hydroxamic acid derivatives as LpxC inhibitors Grant 9,718,792 - Fu , et al. August 1, 2 | 2017-08-01 |
| ISOXAZOLINE HYDROXAMIC ACID DERIVATIVES AS LpxC INHIBITORS App 20170174640 - FU; Jiping ; et al. | 2017-06-22 |
| Isoxazoline hydroxamic acid derivatives as LpxC inhibitors Grant 9,637,482 - Fu , et al. May 2, 2 | 2017-05-02 |
| 2'-Ethynyl Nucleoside Derivatives for Treatment of Viral Infections App 20170112868 - Anandan; Sampath-Kumar ; et al. | 2017-04-27 |
| ISOXAZOLE HYDROXAMIC ACID COMPOUNDS AS LpxC INHIBITORS App 20170088525 - FU; Jiping ; et al. | 2017-03-30 |
| Cyclic peptides and use as medicines Grant 9,566,312 - Fu , et al. February 14, 2 | 2017-02-14 |
| ISOXAZOLINE HYDROXAMIC ACID DERIVATIVES AS LpxC INHIBITORS App 20170029415 - FU; Jiping ; et al. | 2017-02-02 |
| 2'-Ethynyl nucleoside derivatives for treatment of viral infections Grant 9,556,216 - Anandan , et al. January 31, 2 | 2017-01-31 |
| Isoxazole hydroxamic acid compounds as LpxC inhibitors Grant 9,549,916 - Fu , et al. January 24, 2 | 2017-01-24 |
| Hepatitis C Virus Inhibitors App 20160222034 - Qiu; Yao-Ling ; et al. | 2016-08-04 |
| ISOXAZOLE HYDROXAMIC ACID COMPOUNDS AS LpxC INHIBITORS App 20160166548 - FU; Jiping ; et al. | 2016-06-16 |
| Pyrazole aminopyrimidine derivatives as LRRK2 modulators Grant 9,212,173 - Baker-Glenn , et al. December 15, 2 | 2015-12-15 |
| Cyclic Peptides And Use As Medicines App 20150306172 - Fu; Jiping ; et al. | 2015-10-29 |
| Aminopyrimidine derivatives as LRRK2 modulators Grant 9,145,402 - Baker-Glenn , et al. September 29, 2 | 2015-09-29 |
| Fluorine-18 and carbon-11 labeled radioligands for positron emission tomography (PET) imaging for LRRK2 Grant 9,139,566 - Marik , et al. September 22, 2 | 2015-09-22 |
| 2'-Ethynyl Nucleoside Derivatives for Treatment of Viral Infections App 20150232501 - Anandan; Sampath-Kumar ; et al. | 2015-08-20 |
| Cyclic peptides and use as medicines Grant 9,072,696 - Fu , et al. July 7, 2 | 2015-07-07 |
| Pyrazole Aminopyrimidine Derivatives As Lrrk2 Modulators App 20150051238 - Baker-Glenn; Charles ; et al. | 2015-02-19 |
| Pyrazole aminopyrimidine derivatives as LRRK2 modulators Grant 8,815,882 - Baker-Glenn , et al. August 26, 2 | 2014-08-26 |
| Aminopyrimidine derivatives as LRRK2 modulators Grant 8,809,331 - Baker-Glenn , et al. August 19, 2 | 2014-08-19 |
| Aminopyrimidine derivatives as LRRK2 modulators Grant 8,802,674 - Baker-Glenn , et al. August 12, 2 | 2014-08-12 |
| Aminopyrimidine derivatives as LRRK2 modulators Grant 8,796,296 - Baker-Glenn , et al. August 5, 2 | 2014-08-05 |
| Aminopyrimidine derivatives as LRRK2 modulators Grant 8,791,130 - Baker-Glenn , et al. July 29, 2 | 2014-07-29 |
| Cyclic Peptides And Use As Medicines App 20140134132 - Fu; Jiping ; et al. | 2014-05-15 |
| Inhibitors of Burton's tyrosine kinase Grant 8,536,166 - Dewdney , et al. September 17, 2 | 2013-09-17 |
| Aminopyrimidine Derivatives As Lrrk2 Modulators App 20130158057 - Baker-Glenn; Charles ; et al. | 2013-06-20 |
| Aminopyrimidine Derivatives As Lrrk2 Modulators App 20130158006 - Baker-Glenn; Charles ; et al. | 2013-06-20 |
| Fluorine-18 And Carbon-11 Labeled Radioligands For Positron Emission Tomography (pet) Imaging For Lrrk2 App 20130156700 - Marik; Jan ; et al. | 2013-06-20 |
| Aminopyrimidine Derivatives As Lrrk2 Modulators App 20130157999 - Baker-Glenn; Charles ; et al. | 2013-06-20 |
| Aminopyrimidine Derivatives As Lrrk2 Modulators App 20130158032 - Baker-Glenn; Charles ; et al. | 2013-06-20 |
| Aminopyrimidine Derivatives As Lrrk2 Modulators App 20130096102 - Baker-Glenn; Charles ; et al. | 2013-04-18 |
| Methods for treating retroviral infections Grant 8,329,755 - Dunn , et al. December 11, 2 | 2012-12-11 |
| Inhibitors of Bruton's tyrosine kinase Grant 8,299,077 - Berthel , et al. October 30, 2 | 2012-10-30 |
| Heterocyclic antiviral compounds Grant 8,293,778 - Dunn , et al. October 23, 2 | 2012-10-23 |
| Pyrazole Aminopyrimidine Derivatives As Lrrk2 Modulators App 20120157427 - Baker-Glenn; Charles ; et al. | 2012-06-21 |
| Non-nucleoside reverse transcriptase inhibitors Grant 8,063,064 - Kennedy-Smith , et al. November 22, 2 | 2011-11-22 |
| Heterocyclic antiviral compounds Grant 8,063,028 - Billedeau , et al. November 22, 2 | 2011-11-22 |
| Non-nucleoside reverse transcriptase inhibitors Grant 8,026,362 - Kennedy-Smith , et al. September 27, 2 | 2011-09-27 |
| Heterocyclic Antiviral Compounds App 20110207688 - Dunn; James Patrick ; et al. | 2011-08-25 |
| Non-nucleoside reverse transcriptase inhibitors Grant 7,947,709 - Elworthy , et al. May 24, 2 | 2011-05-24 |
| Inhibitors of bruton's tyrosine kinase Grant 7,906,509 - Kennedy-Smith , et al. March 15, 2 | 2011-03-15 |
| Non-nucleoside reverse transcriptase inhibitors Grant 7,906,540 - Sweeney , et al. March 15, 2 | 2011-03-15 |
| Non-nucleoside Reverse Transcriptase Inhibitors App 20110059975 - Kennedy-Smith; Joshua ; et al. | 2011-03-10 |
| Inhibitors of Bruton's Tyrosine Kinase App 20100222325 - Berthel; Steven ; et al. | 2010-09-02 |
| Non-nucleoside reverse transcriptase inhibitors Grant 7,754,919 - Silva , et al. July 13, 2 | 2010-07-13 |
| Non-nucleoside reverse transcriptase inhibitors Grant 7,713,974 - Kennedy-Smith , et al. May 11, 2 | 2010-05-11 |
| Inhibitors of Bruton's Tyrosine Kinase App 20100099659 - Kennedy-Smith; Joshua ; et al. | 2010-04-22 |
| Inhibitors of Bruton's tyrosine kinase Grant 7,683,064 - Dewdney , et al. March 23, 2 | 2010-03-23 |
| Inhibitors of HIV-1 reverse transcriptase App 20100056535 - Arora; Nidhi ; et al. | 2010-03-04 |
| Heterocyclic antiviral compounds Grant 7,666,891 - Dunn , et al. February 23, 2 | 2010-02-23 |
| Methods For Treating Retroviral Infections App 20100041648 - Dunn; James Patrick ; et al. | 2010-02-18 |
| Inhibitors Of Burton's Tyrosine Kinase App 20100004231 - Dewdney; Nolan James ; et al. | 2010-01-07 |
| Inhibitors of Bruton's tyrosine kinase App 20090306041 - Dewdney; Nolan James ; et al. | 2009-12-10 |
| Non-nucleoside reverse transcriptase inhibitors Grant 7,625,897 - Saito , et al. December 1, 2 | 2009-12-01 |
| Methods for treating retroviral infections Grant 7,625,949 - Dunn , et al. December 1, 2 | 2009-12-01 |
| Heterocyclic Antiviral Compounds App 20090170856 - Billedeau; Roland Joseph ; et al. | 2009-07-02 |
| Non-nucleoside reverse transcriptase inhibitors App 20090076045 - Kennedy-Smith; Joshua ; et al. | 2009-03-19 |
| Non-Nucleoside reverse transcriptase inhibitors App 20090012034 - Elworthy; Todd Richard ; et al. | 2009-01-08 |
| Non-nucleoside reverse transcriptase inhibitors App 20080293664 - Billedeau; Roland Joseph ; et al. | 2008-11-27 |
| Non-nucleoside reverse transcriptase inhibitors App 20080249151 - Sweeney; Zachary Kevin ; et al. | 2008-10-09 |
| Nonnucleoside reverse transcriptase inhibitors Grant 7,348,345 - Dunn , et al. March 25, 2 | 2008-03-25 |
| Non-nucleoside reverse transcriptase inhibitors App 20080045511 - Kennedy-Smith; Joshua ; et al. | 2008-02-21 |
| Non-nucleoside reverse transcriptase inhibitors App 20080020981 - Sweeney; Zachary Kevin | 2008-01-24 |
| Nonnucleoside reverse transcriptase inhibitors App 20070179157 - Dunn; James Patrick ; et al. | 2007-08-02 |
| Non-nucleoside reverse transcriptase inhibitors Grant 7,208,509 - Dunn , et al. April 24, 2 | 2007-04-24 |
| Non-nucleoside reverse transcriptase inhibitors App 20070088015 - Silva; Tania ; et al. | 2007-04-19 |
| Non-nucleoside reverse transcriptase inhibitors App 20070078128 - Saito; Yoshihito David ; et al. | 2007-04-05 |
| Non-nucleoside reverse transcriptase inhibitors Grant 7,189,718 - Dunn , et al. March 13, 2 | 2007-03-13 |
| Non-nucleoside reverse transcriptase inhibitors Grant 7,166,738 - Dunn , et al. January 23, 2 | 2007-01-23 |
| Heterocyclic antiviral compounds App 20060025462 - Dunn; James Patrick ; et al. | 2006-02-02 |
| Methods for treating retroviral infections App 20050239880 - Dunn, James Patrick ; et al. | 2005-10-27 |
| Non-nucleoside reverse transcriptase inhibitors App 20050239881 - Dunn, James Patrick ; et al. | 2005-10-27 |
| Non-nucleoside reverse transcriptase inhibitors App 20040198736 - Dunn, James Patrick ; et al. | 2004-10-07 |
| Non-nucleoside reverse transcriptase inhibitors App 20040192704 - Dunn, James Patrick ; et al. | 2004-09-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 